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The  major  histocompatibility complex  (MHC) l  is  normally involved in  the 
regulation of T  lymphocyte reactivity (1).  In the physiologically abnormal situa- 
tion of tissue transplantation,  MHC alloantigens appear to be the major targets 
of the rejection response, at least in first-set responses. Both class I and class  II 
alloantigens can induce rejection responses (2),  and each class of antigen tends 
to induce different types of responses. Thus, although cytotoxic T  lymphocytes 
of the  T  helper phenotype,  which are specific for class  II  antigens,  are well 
documented (e.g., reference 3), cytotoxic T  lymphocytes appear to be mainly of 
the suppressor/cytotoxic phenotype and to be specific for class  I  antigens (4). 
Class  II antigens appear to preferentially stimulate proliferative responses in T 
lymphocytes of the  helper  phenotype  (5),  resulting,  in  vivo,  in  delayed-type 
hypersensitivity (DTH) responses. 
The contributions of T  lymphocytes of the helper and suppressor/cytotoxic 
phenotypes to the rejection response are not entirely clear. T  helper cells are 
certainly critical for the induction of effective rejection responses (6,  7).  The 
contribution  of each  phenotype  to  the  effector mechanisms  of rejection  is, 
however, controversial. On balance, it would seem likely that both cytotoxic T 
cells (directed mainly at class  I antigens) and T  helper cells (stimulated mainly 
by class  II  antigens  for DTH  reactions) contribute to  the rejection of MHC- 
incompatible allografts (6, 7). The parameters of the rejection response provoked 
by an allograft depend on the expression of class I or class II MHC antigens in 
the graft tissue. The efficacy with which the response is provoked, the mechanism 
by  which it  arises,  and  the  development and  culmination of the  reaction all 
depend on the expression and accessibility of class  I or class  II antigens within 
the graft. 
The multitude of data indicating that the MHC expression is pleiotropic might 
therefore be of fundamental importance in transplantation. Many in vitro studies 
with a,/3, and 3' interferons have shown that these agents are potent inducers of 
class I MHC antigens on diverse cell types (e.g., 8, 9) with 3' interferon also being 
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a  potent inducer of class II antigens (9,  10). To our knowledge, class I  antigen 
induction has not been reported in vivo, but class II antigens have been induced 
by graft-vs.-host disease  in  skin  and  colonic epithelium  (11,  12) and  in  kidney 
(13).  Of particular  interest  is  the  induction  of class  II  antigens  on  vascular 
endothelium (14) and epithelial cells (15) in rejecting skin allografts. 
A  characteristic  of virtually  all  types  of rejection  responses  is  a  prominent 
cellular  infiltrate,  with  activated  leukocytes of many  types and  the  release  of 
lymphokines within graft tissues. In such circumstances, donor MHC expression 
in the grafted tissues might be radically altered in the course of rejection, and 
this might play a critical role in the development and execution of the rejection 
response. For this reason, we have studied cardiac allografts for MHC expression 
at  various  stages  during  rejection,  using  immunohistological  techniques  and 
quantitative  absorption  analyses  with  allospecific mouse  monoclonal  xenoanti- 
bodies to rat class I and class II MHC antigens. We report a  massive increase in 
class I expression by day 5 of the rejection process, mainly as a result of induction 
of class I antigens on myocardial cells (which normally express little or no class I 
antigen).  Class  II  antigens,  normally  seen  only on  interstitial  cells,  appear  in 
scattered areas of the myocardium by day 3, and by day 5 both endothelial and 
myocardial cells strongly express class II molecules. 
Materials and Methods 
Animals.  Inbred DA (RT1 a) and PVG (RT1 c) male rats were obtained from OLAC 
1976 Ltd., Bicester, Oxon., England, and were used between 3 and 6 mo of age. 
Heart Transplantation.  Heterotopic heart allografts were performed using microsur- 
gical techniques. After the left kidney was removed, donor hearts were anastomosed to 
the recipient using end-to-end anastomoses between the renal and innominate arteries, 
and between the left branch of the pulmonary artery and the renal vein. Ischemia times 
were in the range of 40-50 min. Heartbeat was checked daily by palpation through the 
abdominal wall. Hearts were excised on days 1, 3, 5, and 7 after transplantation. 
Tissue Homogenates.  50%  tissue homogenates of normal  DA hearts, and  DA-to-DA 
isografted  and  DA-to-PVG  allografted  hearts  (at  day  5  after  transplantation),  were 
prepared. Hearts were removed and frozen immediately at -40 °C until used. On thawing, 
the tissues were minced with scissors in Tris-buffered saline containing proteolytic inhib- 
itors (2.5 mM iodoacetamide, 5 mM EDTA and 2 mM phenyimethylsulfonyl fluoride). 
The tissue was forced through a metal sieve and then mechanically homogenized with a 
Teflon pestle. The homogenate was washed twice in Tris-buffered saline by centrifuging 
at  13,000 g for 20 min, and the second pellet was resuspended in an equal volume of 
Tris-buffered saline and frozen at -40°C until used. All procedures were carried out at 
4 °C or on ice. 
Cell Suspensions.  Spleen cell suspensions were prepared fresh immediately before use. 
Spleens were removed from DA and PVG rats and rinsed in phosphate-buffered saline 
(PBS) to remove excess blood. They were then minced with scissors in PBS and forced 
through a  metal sieve. The resulting cell suspension was washed twice in 0.5% bovine 
serum albumin (BSA) in PBS by centrifuging at 500 g for 10 min. 
Red blood cell (RBC) suspensions were prepared by exsanguinating a rat into a syringe 
containing 200 U of heparin. The blood was washed four times in PBS by centrifuging at 
500 g for 10 min and removing the buffy coat and upper layer of RBC after each wash. 
All cell preparations were done at 4°C or on ice. 
Antibodies.  Immunoadsorbent-purified rabbit F(ab')2  anti-mouse F(ab')2  (RAM) was 
prepared as  described previously (16).  RAM  was  depleted of antibodies cross-reacting 100  MHC  INDUCTION  IN  REJECTING  CARDIAC ALLOGRAFI-S 
with  rat  immunoglobulins  by  passage  through  a  rat  F(ab')2  column,  and  was  then 
designated rat-absorbed RAM. RAM was iodinated using the chloramine T  method. 
The M N 4-91-6 mouse anti-rat class ] monoclonal antibody was prepared in the N uffield 
Dept. of Surgery, John Radcliffe Hospital, Oxford, England, by fusing spleen cells from 
a  BALB/c mouse  immunized  with  pure  DA class  I  MHC  antigens  with  the  myeloma 
NS-1  (M.  R.  Newton and J.  W.  Fabre,  unpublished  observations).  This antibody reacts 
with  a  45,000/12,000  heterodimer,  and  the  target  molecule  has  the  expected  tissue 
distribution  for class I antigens.  It shows a  high degree of allospecificity, reacting with 
DA, PVG RT1 a, and PVG RT1 rl rats, but not PVG, WAG, or LEW rats. 
The F 17-23-2 (17) and F 16-4-4 (18) antibodies have previously been described in detail. 
Both are BALB/c spleen/NS-1  hybridomas. F17-23-2 reacts with I/A class II antigens of 
the DA, LEW, and BN strains, but does not react with the PVG or WAG strains.  F16-4- 
4 reacts with a monomorphic determinant of rat class I antigens. 
The MRC OX6 and MRC OX 17 antibodies react with monomorphic determinants of 
the rat  1/A and  I/E class II homologues, respectively (19).  These two cell  lines were a 
kind  gift  of  Dr.  A.  F.  Williams,  MRC  Immunology  Unit,  Oxford.  All  monoclona[ 
antibodies were used as immune ascites partially purified by ion-exchange chromatogra- 
pby. 
Immunohistology.  Tissue samples (lymph nodes or heart ventricles) for immunohistol- 
ogy were frozen in liquid nitrogen  immediately after harvesting.  Cryostat sections of 5 
#m were cut and air-dried on gelatinized slides,  fixed in acetone, and stored at -20°C 
until  used.  To  stain  the  sections,  the  slides  were  thawed  and  the  appropriate  mouse 
monoclonal  antibody  was  put  on  the  sections  at  saturating  concentrations.  This  was 
incubated  at  room  temperature  for  30  min and  washed  twice  in  Tris-buffered  saline. 
Horseradish peroxidase-coupled rabbit anti-mouse immunoglobulin (Dako, Copenhagen, 
Denmark), was used at a  1:7 dilution in 20% normal rat serum to block antibodies cross- 
reacting with rat immunoglobulins. The second incubation was at 37°C for 30 min and 
the slides were then washed twice. The coloration was developed with diaminobenzidine 
(Sigma  Chemical  Co.,  London) at  6  rag/10  ml  containing  3  #1  of  100  vol  hydrogen 
peroxide. Sections were counterstained with Harris's hemotoxylin. 
Binding Assay.  This  was performed  essentially as described by Morris and  Williams 
(20). All procedures were at 4°C or on ice. Duplicate 25-#1 samples of immune ascites to 
be assayed were transferred to LP3 tubes (Luckham Ltd., Burgess Hilt, Sussex). For class 
It assays, 25 #1 of target DA spleen cells at  10S/ml in 0.5% BSA/PBS was added to each 
tube, and this was incubated for  1 h  on ice. The ceils were then washed twice in  0.1% 
BSA/PBS, and  100 #1 of 12~I-labeled  rat-adsorbed  RAM  in  0.5%  BSA/PBS (~300,000 
cpm/tube) was added to the pellet of the second wash. This was resuspended and incubated 
for 1 h  on ice, and the cells were washed twice as above. The pellet of the second wash 
was resuspended in 0.5 ml of PBS and transferred to fresh LP3 tubes, and the target cell- 
bound  radioactivity  was  measured  in  a  gamma  counter  (LKB  Produkter,  Bromma, 
Sweden).  For class I assays, target cells were RBC at  109/ml in 0.5%  BSA/PBS and the 
RAM used was not depleted of rat cross-reacting antibodies. 
Absorption Analysis.  Initial  titrations  of immune ascites were performed to choose a 
dilution that represented conditions of target antigen excess in the assay system. Absorp- 
tions were then performed at this dilution, by incubating equal volumes (80 #1) of antibody 
at the chosen dilution  in 0.5%  BSA/PBS with tripling  dilutions of homogenates or cell 
suspensions in 0.5%  BSA/PBS.  Again, all procedures were at 4°C or on ice. Absorbing 
tissue was removed by centrifugation, and supernatants were assayed in the binding assay 
as above. 
For the  absorptions,  homogenates were  used at  starting  concentrations as prepared 
above, i.e.,  50% solid tissue,  which corresponded to 25-35 mg homogenate protein/ml. 
Spleen cell suspensions  were used at starting concentrations of 5  x  l0  s nucleated  cells/ 
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Results 
Basic Studies 
In the DA-to-PVG strain combination, cardiac allografts cease to beat on the 
6th-gth d after transplantation.  Individual survival times in our laboratory for 
five grafts were 6, 7, 8, 8, and 9 d. 
In  the initial  series of experiments, three allografts and two isografts were 
removed for immunohistological studies at days 1, 3, 5, and 7 after transplanta- 
tion. All three aliografts at any particular time interval gave virtually identical 
results, as did both isografts at each time interval. This was followed by quanti- 
tative absorptions, which were performed on homogenates of five allografts and 
seven isografts. All grafts were removed on the 5th d after transplantation and 
pooled before homogenization. 
Class I MHC Antigens 
Immunohistological studies. The specificity of the MN4-91-6 antibody for DA is 
demonstrated in Fig.  1, a  and b.  It can be seen that there is strong staining of 
DA lymph node, but no staining at all of PVG lymph node. Clearly, therefore, 
in the DA-to-PVG cardiac allografts, all staining will be of cardiac origin, with 
no contribution from the infiltrating PVG leukocytes. This is obviously critical 
for meaningful evaluation of the following experiments. 
The distribution of class I MHC antigens in the normal DA heart is shown in 
Fig.  1 c.  The  major staining  is  seen  in  interstitial  areas and  probably  mainly 
represents staining of capillary endothelium, with some staining of interstitial 
dendritic cells and  possibly  other leukocytes. The  myocardial cell  membrane 
does not stain for class I antigens, except in the region of the intercalated discs. 
The  myocardial  membrane probably  does  express  small  amounts  of class  I 
antigen, and this becomes obvious in the region of the intercalated discs, because 
of the apposition of the cell membranes. It is also possible, however, that no class 
I antigen is expressed on the surface of the myocardial cells. Allografts removed 
1 d  after grafting were not noticeably different from normal DA hearts, either 
with routine histology or in respect to class I antigen distribution. 
By the 3rd d after transplantation, distinct induction of class I antigens could 
be seen in and surrounding areas of cellular infiltration, as illustrated in Fig. 1 d. 
(Consecutive sections  were  completely negative  with  control  antibodies.)  Al- 
though cellular infiltrates were usually associated with class I antigen induction, 
areas of induction  with  no obvious cellular infiltrate were visible.  There was 
some staining of the myocardial membrane, but much of the staining was diffusely 
intracellular. 
The picture at the 5th d  after transplantation was quite striking, with strong 
staining for class  I antigens throughout the myocardium of the allografts, (Fig. 
1,  e and f).  Strong staining of the myocardial membranes was  obvious.  It  is 
particularly worth noting that there was no staining of the interstitial connective 
tissues, which indicates that most of the class I induction occurs on the myocardial 
cells. 
By day 7 after aliografting, the heartbeat was diminished, and sometimes the 
only activity was surface fibrillation. Histologically, there was much edema and 
necrosis.  Some  patches  of  morphologically  distinguishable  myocardial  cells 102  MHC  INDUCTION  IN  REJECTING  CARDIAC  ALLOGRAFTS t
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FIGURE 2.  Expression  of class  I  MHC antigens in rejecting DA-to-PVG cardiac allografts. 
Quantitative absorption analyses were performed with the MN4-91-6 antibody and homoge- 
hates  of normal  DA  heart  (&)  and  DA-to-PVG  cardiac  allografts  removed  at  5  d  after 
transplantation (A), and DA (O) and PVG (O) spleen cell suspensions. The neat point for spleen 
cells was 5 x  l0  s nucleated cells/m], and for homogenates, 50% solid tissue. Counts per minute 
refer to J2sI-labeled  RAM bound in binding assays,  using DA RBC as targets. 
stained only weakly for class  I antigens, perhaps because they were dying cells. 
Other myocardial cells, however, still stained very strongly for class I antigens. 
The DA-to-DA cardiac isografts, included as controls, gave unexpected results. 
By day 5 it was clear that the myocardial cells were expressing increased levels 
of class I antigen, as shown by membrane staining with the MN4-91-6 antibody 
(Fig.  1 h), but the intensity of staining was much less than with the allografted 
heart. Increased class I expression was seen throughout the isograft, although it 
was weaker in some areas than others. With the isografts, it is important to note 
that the MN4-91-6  antibody reacted with host infiltrating cells, as well as the 
donor heart, but this did not obscure the myocardial staining. 
All of the above immunohistological studies were also performed with  the 
F16-4-4  antibody,  which  reacts  with  a  monomorphic determinant  of class  I 
molecules, in  contrast to  the  MN4-91-6  determinant.  Although this antibody 
stains recipient infiltrating cells in addition to the tissues of the heart graft, the 
results confirmed the strong staining of myocardial cells for class I antigens, and 
mirrored the results with MN4-91-6. 
Quantitative absorption analyses.  The results in Fig. 2 demonstrate that by day 
5  after transplantation  the allografted DA  hearts had increased their level of 
expression of class I antigens by a factor of 10. The absorption curves with DA 
and PVG spleen cells illustrate the specificity of the MN4-91-6 antibody for DA. 
The results given in Fig.  3 show a threefold increase in class  I expression by 
day 5 in DA-to-DA heart isografts. It should be stressed that the absorption by 
the  DA  isograft  will  include  the  recipient  infiltrating  cells,  so  the  threefold A.  D.  MILTON  AND J.  W.  FABRE  105 
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FIGURE 3.  Expression of class I M HC antigens on DA-to-DA cardiac isografts. Quantitative 
absorption analyses were performed with the MN4-91-6 antibody and homogenates of normal 
DA heart (/x) and DA-to-DA cardiac isografts removed 5 d after transplantation (I-1). The neat 
point was  50%  solid tissue.  Counts per minute refer to 1~SI-labeled RAM bound in binding 
assays using DA RBC as targets. 
increase represents an overestimate of the increased donor expression of class I 
antigen. 
Class II Antigens 
Immunohistological studies. The specificity of the F17-23-2 antibody for DA is 
demonstrated in  Fig.  4,  a  and b.  There is intense staining of the DA, but no 
staining of the PVG lymph node. As with the MN4-91-6 antibody, this means 
that F17-23-2 clearly defines antigens of donor origin in the DA-to-PVG cardiac 
allografts. 
It has been demonstrated previously (21) that the only class II-positive struc- 
tures in normal rat heart are interstitial cells (Fig. 4 c). Myocardial cells and the 
endothelium of capillaries and larger vessels are all consistently negative. 
After  1  d,  DA  allografts  looked  exactly  like  normal  hearts  with  routine 
histology and immunohistology using F17-23-2. By day 3, however, as with class 
I  antigens, one could see foci of induction of class  II antigens on myocardial 
cells, usually in association with cellular infiltrates (Fig. 4d). Within these areas 
of induction,  there  appeared  fairly numerous  positive  interstitial  structures, 
which might represent class  II induction on capillaries.  However, as shown in 
Fig. 4 e, the endothelium of large vessels was consistently class II negative at this 
stage. 
By the 5th d after aliotransplantation, there was a strong induction of class II 
antigens  in  the myocardium. As  can  be  seen  in  Fig.  4f,  the  myocardial cell 
membranes were distinctly and strongly positive. Moreover, as shown in Fig. 4g, 
the endothelium of the large vessels was now also strongly positive for class  II 
antigens.  There  was  some  increase  in  the staining  of interstitial  structures 106  MHC  INDUCTION  IN  REJECTING  CARDIAC  ALLOGRAFTS >
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(possibly capillary  endothelium),  but  this  was  not  uniform  through  the  graft. 
Class II antigens were still being strongly expressed in aliografts 7 d after grafting, 
as shown in Fig. 4 h. With the DA-to-DA isografts, we could not see any induction 
of class II antigens. 
All of the above immunohistological studies were repeated with the MRC OX6 
(directed at the I/A homologue) and MRC OX 17 (directed at the I/E homologue) 
antibodies (19).  MRC OX6 and MRC OX17 react with monomorphic determi- 
nants of class II antigens and therefore stain recipient infiltrating cells as well as 
the  tissues of the  graft.  We  used  these  additional  antibodies  for two reasons. 
First, we wanted to confirm our results with F17-23-2 using antibodies directed 
against different determinants on class II molecules. Second, F17-23-2 is directed 
at a  polymorphism  of the  I/A homologue, and  we were interested  in studying 
the I/E homologue as well. 
MRC OX6 showed induction of class II antigens on myocardial and vascular 
endothelial  cells,  the  results  being  precisely the  same  as  those  with  F17-23-2 
(although  staining  of the  cellular  infiltrate  by  MRC  OX6  obscured  matters). 
With MRC OX 17, the staining of the cellular infiltrates was as strong with MRC 
OX6,  but  staining  of the  myocardial  and  vascular  endothelial  cells,  although 
definite, was perceptibly weaker than with MRC OX6. This might simply reflect 
differences in  the  affinity  or  other  properties  of these  two antibodies,  but  it 
could also suggest that induction of I/A class II antigens on myocardial cells was 
substantially more marked than that of I/E class II antigens. 
Quantitative  absorption analyses.  The  F17-23-2  antibody  proved  unsuitable 
for absorption analyses over a wide range of dilutions. This was probably because 
of low affinity and consequent failure to achieve low free-antibody concentrations 
even with excess antigen  in the absorption.  This was also the case for the MRC 
OX17  antibody,  but  MRC  OX6  gave  good  absorption  curves.  We  therefore 
proceeded with absorptions using the MRC OX6 antibody, even though it does 
not distinguish  donor  class  II  from  recipient  class II  on  infiltrating  cells.  The 
results  in  Fig.  5  show that  the content  of class  II  antigen  in  the allograft  had 
increased substantially by day 5, from nondetectable levels at the time of grafting. 
Although by immunohistology,  much of the class II antigens in the allograft at 
day  5  appeared  to  be on  myocardial  cells,  it  is  not possible to determine  the 
relative  contributions  of the  donor  myocardial  cells  and  recipient  infiltrating 
cells to the absorption seen in Fig. 5. 
Discussion 
The constitutive expression of class I molecules on most nucleated cells might 
be concerned with the effective presentation  of foreign (e.g.,  viral) antigens  to 
T  lymphocytes, particularly cytotoxic T  iymphocytes. The level of expression of 
class I molecules in different tissues varies markedly (22), and, in some cells (e.g., 
exocrine cells of the pancreas and  salivary glands),  class I  molecules cannot  be 
demonstrated,  even  with  sensitive  immunohistological  techniques  (23).  The 
factors involved in regulating class I antigen expression are not known, but a, B, 
and "y interferons  have been shown to increase the level of expression in many 
cell  types in  vitro  (9,  10).  The  physiological  role of interferon-induced  class  I A.  D.  MILTON  AND J.  w.  FABRE 
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FIGURE 5,  Expression of class  II (I/A) antigens in rejecting DA-to-PVG cardiac allografts. 
Quantitative absorption analyses were performed with the MRC OX6 antibody, and homog- 
enates of normal DA heart (A) and DA-to-PVG cardiac allografts removed 5 d after transplan- 
tation (&) and DA (©) and PVG (0) spleen cells.  The neat point for spleen cells was 5 x  108 
nucleated cells/ml, and for homogenates,  50% solid tissue. Counts per minute refer to ~is1- 
labeled rat-absorbed  RAM (see  Materials and  Methods) bound  in binding assays  using DA 
spleen cells as targets. 
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antigen expression might be to increase the effectiveness of antigen presentation 
to cytotoxic T  lymphocytes in areas of inflammation. 
Class II antigens are constitutively expressed on many fewer cell types (e.g., B 
lymphocytes, dendritic-type cells, and certain  epithelia) (24).  ~'  Interferon  has 
been shown to induce class II antigens on various cell types in vitro (9,  10). It is 
likely that this lymphokine is responsible for the expression of class II antigens 
on activated macrophages and T  lymphocytes (9), on skin and colonic epithelium 
(11,  12)  and  kidney  during  graft-vs.-host  disease  (13),  and  on  the  vascular 
endothelium (14) and epithelial cells (15) of rejecting skin allografts.  It might 
also  be  responsible  for  the  patchy  expression  of class  II  antigens  on  some 
colorectal tumor cells (25).  As with class I antigen induction, the physiological 
role of class II antigen induction might be to improve antigen presentation (to 
T  helper cells) at sites of inflammation. This possibility is greatly strengthened 
by the recent demonstration (in transfection experiments with mouse fibroblasts) 
that class II antigen expression is by itself sufficient for effective antigen pres- 
entation by a cell (26). 
It can be argued that MHC antigen induction at sites of inflammation might 
represent a favorable adaptive response, improving host defenses and therefore 
favoring the individual's survival. However, in the unnatural situation of a tissue 
graft residing in a foreign host, this response is very likely to evoke more effective 
rejection responses and lead to the demise of the graft (and sometimes its host). 
In the particular situation examined in our experiments, the  10-fold increase 110  MHC  INDUCTION  IN  REJECTING  CARDIAC  ALLOGRAFTS 
in donor class  I antigen expression by the rejecting heart, probably mainly on 
myocardial cells, would probably  increase the susceptibility of the myocardial 
cells to class I-specific cytotoxic T cells, especially since myocardial cells normally 
express few, if any, class  I  molecules. This increased level of expression might 
also favor the maturation of class I-specific cytotoxic T  cell precursors. 
The expression of class II molecules on both myocardial and endothelial cells 
could be of particular importance, because of the major role played by these 
molecules in T  helper lymphocyte activation. The large-scale induction of class 
II antigens in the rejecting heart might greatly augment activation of T  helper 
cells and thereby provide a continued source of T  helper cell-derived 3" inter- 
feron to maintain class  II (and class I) antigen induction in the myocardial and 
endothelial cells. In this way, an expanding and self-regenerating cycle could be 
initiated that would terminate with the destruction of the graft. The induced 
class  II antigens could also serve as new targets on endothelial and myocardial 
cells for class II-specific cytotoxic T  cells, and, as indicated above, might enable 
the myocardial cells to present class I and minor alloantigens to T  helper cells. 
The induction of class I MHC antigens on the DA-to-DA cardiac isografts was 
unexpected.  It  is  possible  that  activation  of graft  macrophages and  dendritic 
cells, and perhaps the infiltration of the graft with recipient macrophages as a 
result of the surgical trauma and ischemia at  the time of transplantation,  are 
responsible. The activated macrophages might secrete a and/3 interferons, which 
are potent inducers of class I but not class II MHC antigens (10). The induction 
of class  II antigen probably requires infiltration of the graft with activated T 
lymphocytes secreting 3' interferon, and this would occur only in the allograft 
situation. 
In conclusion, we would like to stress that the strong induction of class I and 
class  II MHC antigens during the rejection process, initiated at sites of perivas- 
cular infiltration,  presumably by the release of lymphokines, might provide a 
strong driving force for rejection responses, and could also increase the graft's 
vulnerability to the rejection process by providing a more effective target for the 
host's immune system. 
Summary 
DA (RT 1") hearts were transplanted into PVG (RT 1  c) or DA recipients, excised 
on  days  1,  3,  5,  or  7  after  grafting,  and  examined  by  immunohistological 
techniques and quantitative absorption analyses, using allospecific mouse anti-rat 
class I and class II major histocompatibility complex (MHC) monocional antibod- 
ies. Cryostat sections stained by the peroxidase technique demonstrated that, in 
the normal heart, class I antigens were largely restricted to vascular endothelium 
and interstitial cells, with no observable staining of the myocardial cells except 
at the intercalated discs. Class  II antigens were found only on occasional inter- 
stitial dendritic cells. The picture at day 1 after transplantation was not noticeably 
different. By day 3,  however, there was clear patchy induction of both class  I 
and class  II antigens on the myocardial cells,  usually in the region of cellular 
infiltrates. By day 5, class I antigens had been strongly induced throughout the 
graft, with  the myocardial cells being very strongly positive.  Class  II antigens 
were also uniformly expressed on myocardial cells at day 5, and at this stage the A.  D.  MII.TON  AND J.  W.  FABRE  11 1 
wiscular endothelium was also strongly positive. Quantitative absorption analyses 
showed a  10-fold increase in class I antigen content in cardiac allografts at day 5 
after transplantation when compared with normal DA heart. DA heart isografts 
showed no increase in class II antigens, but it was interesting that, by 5  d  after 
grafting,  there  appeared  to  be  some  expression  of class  I  antigens  on  the 
myocardial ceils. Quantitative absorptions showed a threefold increase in class I 
antigens on 5-d isografts when compared with normal DA heart. 
Received for publication  6 August 1984. 
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